A 55-year-old woman with IgA nephropathy has a urine protein-to-creatinine ratio of 1.8 g/g and eGFR of 52 mL/min/1.73m².Which additional therapy beyond RAS blockade has demonstrated benefit in slowing CKD progression in this condition?
